Advertisement

Topics

Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01082017] Prices from USD $175

14:34 EDT 19 Sep 2017 | BioPortfolio Reports

Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report

Summary

Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Ionis Pharmaceuticals Ionis or 'the company', formerly known as Isis Pharmaceuticals, uses antisense technology, a drug discovery platform, to discover and develop novel drugs for its product pipeline and also for its partners. The company primarily operates in the US. It is headquartered in Carlsbad, California, and employed 390 people as of February 17, 2015.

Scope

Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
An indepth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Original Article: Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01082017] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01082017] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antisense therapy
Most human diseases are caused by production of abnormal proteins or malfunctioning proteins.   Antisense therapy involves inhibiting production of these proteins.  When a gene is known to cause a specific disease and the genetic sequence ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...